These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6134424

  • 1. Aspects of inhibition of myometrial hyperactivity in primary dysmenorrhea.
    Forman A, Ulmsten U, Andersson KE.
    Acta Obstet Gynecol Scand Suppl; 1983; 113():71-6. PubMed ID: 6134424
    [Abstract] [Full Text] [Related]

  • 2. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
    Sun L, Liu L, Zong S, Wang Z, Zhou J, Xu Z, Ding G, Xiao W, Kou J.
    J Ethnopharmacol; 2016 Sep 15; 191():273-279. PubMed ID: 27340106
    [Abstract] [Full Text] [Related]

  • 3. Effects of calcium channel blockers on the female genital tract.
    Forman A, Andersson KE, Maigaard S.
    Acta Pharmacol Toxicol (Copenh); 1986 Sep 15; 58 Suppl 2():183-92. PubMed ID: 3521196
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mares with delayed uterine clearance have an intrinsic defect in myometrial function.
    Rigby SL, Barhoumi R, Burghardt RC, Colleran P, Thompson JA, Varner DD, Blanchard TL, Brinsko SP, Taylor T, Wilkerson MK, Delp MD.
    Biol Reprod; 2001 Sep 15; 65(3):740-7. PubMed ID: 11514336
    [Abstract] [Full Text] [Related]

  • 6. Calcium antagonists and dysmenorrhea.
    Andersson KE.
    Ann N Y Acad Sci; 1988 Sep 15; 522():747-56. PubMed ID: 3288067
    [No Abstract] [Full Text] [Related]

  • 7. Calcium entry blockade as a therapeutic principle in the female urogenital tract.
    Forman A.
    Acta Obstet Gynecol Scand Suppl; 1984 Sep 15; 121():1-26. PubMed ID: 6588719
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A rationale for the treatment of dysmenorrhea.
    Csapo AI.
    J Reprod Med; 1980 Oct 15; 25(4 Suppl):213-21. PubMed ID: 7001020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New concepts in dysmenorrhea.
    Ylikorkala O, Dawood MY.
    Am J Obstet Gynecol; 1978 Apr 01; 130(7):833-47. PubMed ID: 25021
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of mare uterus motility with special reference to calcium antagonists and beta-2-adrenergic stimulants.
    Coruzzi G, Poli E, Montanari C, Bertaccini G.
    Gen Pharmacol; 1989 Apr 01; 20(4):513-8. PubMed ID: 2568969
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandins and the non-pregnant uterus. The pathophysiology of primary dysmenorrhea.
    Pulkkinen MO.
    Acta Obstet Gynecol Scand Suppl; 1983 Apr 01; 113():63-7. PubMed ID: 6344545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea.
    Andersson KE, Ulmsten U.
    Br J Obstet Gynaecol; 1978 Feb 01; 85(2):142-8. PubMed ID: 626724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O, Joelsson I.
    Acta Obstet Gynecol Scand; 1981 Feb 01; 60(3):229-32. PubMed ID: 7270089
    [Abstract] [Full Text] [Related]

  • 20. Pathophysiology of dysmenorrhea.
    Akerlund M.
    Acta Obstet Gynecol Scand Suppl; 1979 Feb 01; 87():27-32. PubMed ID: 380250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.